Spectrum of Adolescent Marijuana Use in Secondary Schools at Sagamu, South-West Nigeria: Factors, Determinants and Scope
DOI:
https://doi.org/10.54536/ajlsi.v3i2.2993Keywords:
Spectrum, Adolescent, Marijuana Use, Secondary Schools, Sagamu, South-West Nigeria, Factors, Determinants, ScopeAbstract
Adolescents’ use of marijuana is a challenge of public health concern, and this also relates to several communities in Nigeria. The use of marijuana and other substances has been reported among the youths. However, the contributing factors to its consumption among these consumers are yet to be fully documented in some Nigerian states. This research aimed to investigate the spectrum of marijuana use among adolescents in secondary schools at Sagamu. The study employed a descriptive, cross-sectional design. A multi-stage sampling technique was used to select 388 respondents. A semi-structured questionnaire with Cronbach’s alpha of 0.72 was employed. The predisposing, reinforcing, and enabling factors were measured on an 18-point rating scale. Pearson’s correlation and linear regression analysis were conducted to give statistical responses to the research hypotheses using SPSS version 23. The response rate in this research was 98%. The mean age of the respondents was 15.46±1.37years. 56.2% were females, 74.5% were Christians, and 84% were Yoruba. 4.6% of the respondents have an uneducated dad, 3.9% have an uneducated mum, 70.6% have a self-employed dad, and 78.1% have a self-employed mum. 92.5% of the respondents have a good knowledge of marijuana use. 77.6% have a positive attitude towards marijuana use. 48.7% of the respondents could be influenced by the reinforcing and enabling factors, and there was a 7.2% prevalence rate of marijuana use. There was a significant association between peer influence and marijuana use (R=0.105; R2=0.11; p=0.39), but none between respondents’ predisposing factors and marijuana use (p>0.05). Peer influence was the only significant determinant of marijuana use among the respondents. Peer education from homes, schools, and governments is therefore recommended to promote the non-use of marijuana and other substances among adolescents.
Downloads
References
Abudu, R. V. (2008). Young people and drugs abuse. Biennial International Conference on Alcohol, Drugs and Society in Africa, 23rd - 25th July 2008, Abuja, FCT, Nigeria.
Adekeye, O. (2012). Knowledge level and attitude of school-going male adolescents toward drug use and abuse. Kontagora Journal of Education, 12, 122-130. Kotangora, Niger State, Nigeria.
Adekeye, O. A., Adeusi, S. O., Chenube, O. O., Ahmadu, F. O., & Sholarin, M. A. (2015). Assessment of alcohol and substance use among undergraduates in selected private universities in Southwest Nigeria. IOSR Journal of Humanities and Social Science, 20(3), 1-7.
Ajibola, I. A., Aremu, A., & Ayotunde, O. (2018). Substance abuse among students in selected secondary schools of an urban community of Oyo State, Southwest Nigeria: Implication for policy action. African Journals Online, 18(3), 776–785. DOI: 10.4314/ahs.v18i3.36.
Akannam, T. (2008). North-West ranks highest in drug addiction. Nigerian Drug Statistics by Zone. Available online: http://www.nairaland.com/203955/nigerian-drug-statistics-zone
Almahdi, H. M., Ali, R. W., Nasir, E. F., & Åstrøm, A. N. (2018). Socio-cognitive correlates of intention to use Toombak: A cross-sectional study among students (13–16 years) in Khartoum State, Sudan. BMC Public Health, 18(88), 1-9. DOI: 10.1186/s12889-017-4606-z.
Ama, M. I., Ikwuka, A. O., Udeh, F. C., Ekechi, H. O., & Eteudo, A. N. (2023). Sperm Parameters and Testicular Histology of Male Wistar Rats Treated with Phoenix dactylifera After Consumption of Local Mmahi Salt. American Journal of Bioscience and Bioinformatics, 2(1), 41-51. DOI: 10.54536/ajbb.v2i1.2275.
Baysah, P. V., Ikwuka, A. O., Udeh, F. C., Bleh, D. P., & Viloria, T. (2023). Pathophysiological effects of alcohol and tobacco consumption on semen parameters of men attending a fertility clinic in West Africa. American Journal of Biomedical and Life Sciences, 11(4), 73-81. DOI: 10.11648/j.ajbls.20231104.13.
Centers for Disease Control and Prevention. (2023). Marijuana and Public Health: Health Effects. Available online: https://www.cdc.gov/marijuana/index.htm
Center on Addiction and Substance Abuse (2011). Adolescent Substance Use: America’s #1 Public Health Problem. The National Center on Addiction and Substance Abuse at Columbia University. Available online: https://cdn-01.drugfree.org/web/prod/wp-content/uploads/2011/06/19202754/Adolescent-substance-use-americas-no-1-public-health-problem.pdf
Duru, C. B., Oluoha, U. R., Okafor, C. C., Diwe, K. C., Iwu, A. C., Aguocha, C. M., Ohale, I., & Nwaigbo, E. (2017). Socio-demographic determinants of psychoactive substance use among students of tertiary institutions in Imo State, Nigeria. Journal of Addiction Research & Therapy, 8(345), 1-9. DOI: 10.4172/2155-6105.1000345.
Ekechi, H. O., Ikwuka, A. O., Udeh, F. C., & Abraham, J. C. (2023)a. Effects of Ethanol Extract of Rauwolfia vomitoria Leaf on Lipid Profile and Cerebellar Histology in Cisplatin-induced Oxidative Stress. British Journal of Medical and Health Research, 10(5), 16-39. DOI: 10.5281/zenodo.8042521.
Ekechi, H. O., Ikwuka, A. O., Udeh, F. C., Epete, M. A., & Uche, V. U. (2023)b. Hepatorenal Protective Functions of Coconut Water in Alloxan-Induced Type 1 Diabetes Mellitus. World Journal of Current Medical and Pharmaceutical Research, 5(4), 114-122. DOI: 10.37022/wjcmpr.v5i4.276.
English, F., & Whitehill, J. M. (2023). Risk factors for adolescent cannabis use in a state with legal recreational cannabis: The role of parents, siblings, and friends. Clinical Therapeutics, 45(6), 589-598. DOI: 10.1016/j.clinthera.2023.04.002.
European Monitoring Center for Drugs and Drug Addiction (EMCDDA). (2023). European drug report 2023: Trends and developments. Available online: https://www.emcdda.europa.eu/publications/european-drug-report/2023_en
Global Burden of Disease Collaborative Network. (2015). Global burden of disease study 2013 (GBD 2013): incidence, prevalence, and years lived with disability 1990-2013. Institute for Health Metrics and Evaluation (IHME). Available online: https://ghdx.healthdata.org/record/ihme-data/gbd-2013-incidence-prevalence-and-ylds-1990-2013
Gloss, D. (2015). An overview of products and bias in research. Neurotherapeutics. 12(4), 731-734.
Gotsang, G., Mashalla, Y., & Seloilwe, E. (2017). Perceptions of school-going adolescents about substance abuse in Ramotswa, Botswana. Journal of Public Health and Epidemiology, 9(6), 151-160. DOI: 10.5897/JPHE2017.0930.
Ikwuka, A. O. (2015). Risk factors for the pathogenesis of diabetes mellitus type 2. Materials of 84th Scientific and Practical Conference of Students and Young Scientists with International Participation “Innovations in medicine”, p. 19. Available online: http://www.ifnmu.edu.ua/images/snt/files/konferenciya/Tezu_2015.pdf
Ikwuka, A. O. (2017)a. Dyslipidemia risk severity in patients with diabetes mellitus type 2 and essential hypertension. Journal of the 21st International Medical Congress of Students and Young Scientists, p. 59.
Ikwuka, A. O. (2017)b. Effectiveness of dapagliflozin in patients with diabetes mellitus type 2 and essential hypertension. Book of abstracts of the 7th International Students’ Scientific Conference of Young Medical Researchers, p. 102. Available online: http://www.stn.umed.wroc.pl/files/lm/Accepted_papers.16113.pdf
Ikwuka, A. O. (2017)c. Influence of dyslipidemia in patients with diabetes mellitus type 2 and essential hypertension. The Pharma Innovation Journal, 6(3), 101-103. Available online: http://www.thepharmajournal.com/archives/?year=2017&vol=6&issue=3&part=B
Ikwuka, A. O., & Haman, I. O. (2017)d. Features of kidney damage in patients with diabetes mellitus type 2 and essential hypertension. Journal of 86th Scientific and Practical Conference of Students and Young Scientists with International Participation “Innovations in medicine”, p. 144. Available online: http://www.ifnmu.edu.ua/images/snt/86-konf-tezi%20(1).pdf
Ikwuka, A. O., Virstyuk, N. G., & Luchko, O. R. (2017)e. Features of the functional state of kidneys in patients with diabetes mellitus type 2 and essential arterial hypertension. Materials of scientific-practical conference with international participation “Babenkivski reading”, p. 48.
Ikwuka, A. O. (2018)a. Clinical dynamics in patients with diabetes mellitus type 2 and concomitant essential hypertensive disease treated with dapagliflozin. Journal of the 22nd International Medical Congress of Students and Young Scientists, p. 32.
Ikwuka, A. O. (2018)b. Clinical effectiveness of SGLT-2 inhibitors in patients with diabetes mellitus type 2 and essential hypertensive disease. Endocrine Practice, 24(1), 74. DOI: 10.1016/S1530-891X(20)47129-0.
Ikwuka, A. O. (2018)c. Features of kidney damage in patients with arterial hypertension and type 2 diabetes mellitus and optimization of treatment. Specialized Academic Council IFNMU, Available online: http://www.ifnmu.edu.ua/images/zagalna_informacia/spec_vcheni_radi/2017-2019/%D0%9420.601.01/Ikvuka/Avtoreferat.pdf
Ikwuka, A. O., & Paliy, Yu. (2018)d. Structural changes of the left ventricular myocardium in patients with essential arterial hypertension and diabetes mellitus type 2. Abstracts of the 87th Scientific Conference of Students and Young Scientists with International Participation “Innovations in medicine”, p. 25-26. Available online: https://www.ifnmu.edu.ua/images/snt/zaproshennia_eng.pdf
Ikwuka, A. O. (2019)a. Clinical dynamics of nephropathy in patients with diabetes mellitus type 2 and concomitant essential hypertensive disease. Clinical Medicine, 19(2), s39. DOI: 10.7861/clinmedicine.19-2-s39.
Ikwuka, A. O. (2019)b. Clinical effectiveness of GLP-1 RAs in patients with metabolic syndrome diseases. Endocrine Practice, 25(1), 104-105. DOI: 10.1016/S1530-891X(20)46611-X.
Ikwuka, A. O., & Virstyuk, N. G. (2019)c. Pattern of cardiac remodelling of the left ventricle in patients with essential hypertensive disease and concomitant type 2 diabetes mellitus. Clinical Medicine, 19(3), s92. DOI: 10.7861/clinmedicine.19-3-s92.
Ikwuka, A. O., & Virstyuk, N. G. (2021). Influence of SGLT2 inhibitor and A2RB (AT1) on fibrogenesis and heart failure in patients with essential hypertensive disease combined with diabetes mellitus type 2. E-Poster No. 143 of the 44th & 45th Annual General and Scientific Meeting of the West African College of Physicians (WACP), 1 - 3 November, 2021. DOI: 10.13140/RG.2.2.26912.87047.
Ikwuka, A. O., & Virstyuk, N. (2022). Prognostic markers of nephropathy in patients with dual metabolic syndrome diseases (essential hypertensive disease and concomitant type 2 diabetes mellitus). Endocrine Practice, 28(5), S65-S66. DOI: 10.1016/j.eprac.2022.03.164.
Ikwuka, A. O. (2023)a. Dr. Aloy's Core Essential Series (DACES) Medical Genetics. 1st Edition. Science and Education Publishing, USA, p. 15. ISBN: 978-1-958293-02-7.
Ikwuka, A. O. (2023)b. Dr. Aloy's Core Essential Series (DACES) Immunology. 1st Edition. Science and Education Publishing, USA, p. 30. ISBN: 978-978-795-866-7.
Ikwuka, A. O., & Virstyuk, N. (2023)c. Patterns and Influence of Cardio-Metabolic Insufficiency in Patients with Essential Hypertensive Disease and Concomitant Type 2 Diabetes Mellitus. Endocrine Practice, 29(5), S32-S33. DOI: 10.1016/j.eprac.2023.03.076.
Ikwuka, A. O., Virstyuk, N. G., Luchko, O. R., & Kobitovych, I. (2023)d. Heterogeneity Of Renal Pathogenicity On The Background Of Asymptomatic Hyperuricemia In Patients With Dual Metabolic Syndrome Diseases (Essential Hypertensive Disease and Type 2 Diabetes Mellitus). British Journal of Medical and Health Research, 10(2), 1-9. DOI: 10.5281/zenodo.7690636.
Ikwuka, A. O. (2023)e. Dr. Aloy's Core Essential Series (DACES) Hematology. 1st Edition. Science and Education Publishing, USA, p. 84. ISBN: 978-1-958293-09-6.
Ikwuka, A. O., Omoju, D. I., & Mahanera, O. K. (2023)f. Profiling of Clinical Dynamics of Type 2 Diabetes Mellitus in Patients: A Perspective Review. World Journal of Current Medical and Pharmaceutical Research, 5(5), 210-218. DOI: 10.37022/wjcmpr.v5i5.294.
Ikwuka, A. O., Virstyuk, N., Luchko, O., & Kobitovych, I. (2024). Optimization of treatment in MSD patients using a combination of HMG-CoA reductase inhibitor, SGLT-2 inhibitor and A2RB (AT1): Resultant clinical effectiveness. Endocrine Practice, 30(5), S60-S61. DOI: 10.1016/j.eprac.2024.03.243.
Jacobs, G. P., Golshan, T., Lande, S., Nickfardham, K., Roitblat, Y., Morgan, A., Mayo, T., Mametov, K., Nehuliaieva, L., & Shterenshis, M. (2021). Knowledge and attitude of adolescents to marijuana: an international prospective study. Children and Youth Services Review, 131(2), 106306. DOI: 10.1016/j.childyouth.2021.106306.
Kugbey, N. (2023). Prevalence and correlates of substance use among school-going adolescents (11-18 years) in eight Sub-Saharan African countries. Substance Abuse Treatment, Prevention, and Policy, 18(1), 44 -52. DOI: 10.1186/s13011-023-00542-1.
Musa, S., Ikwuka, A. O., Udeh, F. C., Musa, A. A., & Chukwuezie, U. C. (2023). CRISPR-Cas9 Genomic Editing as an Innovation in the Management of Sickle Cell Disease: A Systematic Review. American Journal of Medical Science and Innovation, 2(2), 36-48. DOI: 10.54536/ajmsi.v2i2.1760.
National Academies of Sciences, Engineering, and Medicine. (2017). The Health Effects of Cannabis and Cannabinoids: The Current State of Evidence and Recommendations for Research. Washington, DC: The National Academies Press. DOI: 10.17226/24625.
National Center for Complementary and Integrative Health. (2018). Marijuana and cannabinoids. Available online: https://nccih.nih.gov/health/marijuana
National Center for Drug Abuse Statistics. (2024). Marijuana Addiction: Rates & Usage Statistics. Available online: https://drugabusestatistics.org/marijuana-addiction/
Ojieabu, W. A., Eze, U. I. H., Ojieabu, C. I., & Osunkoya, O. K. (2017). Substance abuse in Sagamu Local Government of Ogun State. Nigerian Journal of Pharmaceutical Research. 11(1), 140-146. Available online: www.ajol.info/index.php/njpr/article/view/163016
Oriavwote, P. E., & Ikwuka, A. O. (2022). Patterns and factors influencing self-medication among students of the American International University West Africa (AIUWA), The Gambia. European Journal of Clinical Medicine, 3(2), 33-37. DOI: 10.24018/clinicmed.2022.3.2.181.
Peterson, C., Li, M., Xu, L., Mikosz, C. A., & Luo, F. (2021). Assessment of annual cost of substance use disorder in US hospitals. JAMA Network Open, 4(3), e210242. DOI: 10.1001/jamanetworkopen.2021.0242.
Statista. (2023). Estimated number of cannabis users worldwide from 2011 to 2021, by region. Health, Pharma and Medtech. John Elflein Publisher.
Uche, V. U., Ikwuka, A. O., Udeh, F. C., Okorocha, A. E., Epete, M. A., Ekechi, H. O., Abraham, J. C., & Igwe, E. C. (2023). Associated Risks and Pathogenic Effects of Consumption of Calcium Carbide-Ripened Banana Before and/or During Pregnancy on Maternal and Neonatal Livers. American Journal of Food Science and Technology, 2(2), 54-64. DOI: 10.54536/ajfst.v2i2.2197.
Udeh, F. C., Ikwuka, A. O., Epete, M. A., & Igwe, E. C. (2023)a. Effects of Local Tobacco Snuff Ingestion during Pregnancy on Renal Functions and Histology Architecture of Female Wistar Rats and on the Birth Weight of Their Pups. American Journal of Medical Sciences and Medicine, 11(1), 1-5. DOI: 10.12691/ajmsm-11-1-1.
Udeh, F. C., Ikwuka, A. O., Epete, M. A., & Igwe, E. C. (2023)b. Effects of Oral Consumption of Nicotiana Tabacum During Pregnancy on the Liver and Prolactin Levels of Adult Female Wistar Rats. European Journal of Veterinary Medicine, 3(2), 1-5. DOI: 10.24018/ejvetmed.2023.3.2.93.
Udeh, F. C., Ikwuka, A. O., Nwandu, T. C., Ewunonu, E. O., Egwu, O. A., Ezinwa, G. A., & Anaetor, I. S. C. (2023)c. Human Anatomy Education: Knowledge, attitude, perception and challenges encountered by medical and nursing students in two Gambian Universities. Journal of Tertiary Education and Learning, 1(3), 29-38. DOI: 10.54536/jtel.v1i3.2277.
United Nations Children’s Emergency Fund. (2022). Investing in a safe, healthy and productive transition from childhood to adulthood is critical. Adolescent. Available online: https://data.unicef.org/topic/adolescents/overview/
United Nations Office of Drugs and Crime. (2021). World Drug Report 2021. United Nations. Available online: https://www.unodc.org/unodc/data-and-analysis/wdr2021.html
Vidot, D. C., Prado, G., Hlaing, W. M., Florez, H. J., Arheart, K. L., & Messiah, S. E. (2016). Metabolic Syndrome Among Marijuana Users in the United States: An Analysis of National Health and Nutrition Examination Survey Data. The American Journal of Medicine, 129, 173-179.
Virstyuk, N. G., Ikwuka, A. O., Haman, I. O., & Adebomi, M. S. (2016). Diabetes mellitus type 2, arterial hypertension and dyslipidemia. Materials of 2nd International Scientific and Practical Conference "Therapeutic readings: modern aspects of diagnosis and treatment of diseases of internal organs", p. 46-47.
Virstyuk, N. G., & Ikwuka, A. O. (2017)a. Diagnostic and prognostic markers of the diabetes mellitus type 2 course in connection with essential arterial hypertension taking into account the kidney function. Precarpathian Journal Pulse, 8(44), 53-62.
Virstyuk, N. H., Ikwuka, A. O., Losyuk, L. V., Kobrynska, O. Ya., & Markiv, H. D. (2017)b. Dapagliflozin utility in patients with diabetes mellitus type 2 and essential hypertensive disease. Actual Problems of Modern Medicine, 4(60)1, 76-79. Available online: http://www.umsa.edu.ua/journal2stat4_2017_eng.html
Virstyuk, N. G., & Ikwuka, A. O. (2018)a. Features of asymptomatic hyperuricemia in patients with diabetes mellitus type 2 and concomitant essential arterial hypertension. Clinical and Experimental Pathology, 1(63), 22-26. DOI: 10.24061/1727-4338.XVII.1.63.2018.5.
Virstyuk, N. G., Ikwuka, A. O., & Didushko, O. M. (2018)b. Effect of dapagliflozin on the level of uric acid during asymptomatic hyperuricemia in patients with diabetes mellitus type 2 and concomitant arterial hypertension. Art of Medicine, 1(5), 21-26. Available online: https://art-of-medicine.ifnmu.edu.ua/index.php/aom/article/view/179/150
Virstyuk, N. H., & Ikwuka, A. O. (2018)c. Dapagliflozin influence on the clinical course of diabetes mellitus type 2 and essential hypertension in patients. Recent Advances in Environmental Science from the Euro-Mediterranean and Surrounding Regions, p. 2007-2008. DOI: 10.1007/978-3-319-70548-4_582.
Virstyuk, N. G., & Ikwuka, A. O. (2019). Nephropathic characteristics in patients with diabetes mellitus type 2 and essential hypertensive disease. Art of Medicine, 1(5), 44-47. DOI: 10.21802/artm.2019.1.9.44.
Virstyuk, N. G., & Ikwuka, A. O. (2021)a. Asymptomatic hyperuricemia and functional state of the kidneys in patients with essential arterial hypertension and concomitant diabetes mellitus type 2. European Journal of Clinical Medicine, 2(3), 100-104. DOI: 10.24018/clinicmed.2021.2.3.65.
Virstyuk, N. H., Ikwuka, A. O., Luchko, O. R., & Kocherzhat, O. I. (2021)b. Peculiarities of renal insufficiency in patients with diabetes mellitus type 2 and arterial hypertension. Materials of scientific-practical conference with international participation "Achievements and prospects of experimental and clinical endocrinology" Twentieth Danilevsky readings, p. 86-87.
World Health Organization Alcohol, Drugs and Addictive Behaviours Unit. (2016). The health and social effects of non-medical cannabis use. Cannabis. Available online: https://www.who.int/substance_abuse/publications/cannabis_report/en/index4.html
World Health Organization Alcohol, Drugs and Addictive Behaviours Unit. (2024). Cannabis. Available online: https://www.who.int/teams/mental-health-and-substance-use/alcohol-drugs-and-addictive-behaviours/drugs-psychoactive/cannabis
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 Ejiroghene Oluwafunke Okorosobo, Ademola Mufutau Amosu, Aloysius Obinna Ikwuka, Francis Chigozie Udeh
This work is licensed under a Creative Commons Attribution 4.0 International License.
